Their study, published in Oncogene, explores how increased methylmalonic acid impairs the activation and effector functions of CD8+ T cells, immune cells that play a vital role in fighting cancer.
Tumors find different ways to avoid immune cell detection and proliferate in their environment. Antitumor immune cells will ...